ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Deconstructing Central Rating In Clinical Trials

  Analyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success in this

• The Future Of EDC Systems

  Gain insight from EDC users in sponsor organizations and CROs regarding anticipated trends in the next two years and how EDC systems can align with decentralized clinical trials.

• Advancing Patient-Centric Research With DHTs

  Sleep quality is pivotal for overall health. Explore how wearable digital health technologies can revolutionize our understanding of sleep and enhance research outcomes.

• How Cara Therapeutics Increased Compliance And Reduced Study Team Burden

  Delve into the partnership that helped Cara Therapeutics achieve a significant milestone in their clinical research efforts to transform the lives of chronic pruritus patients.

• The Benefits Of Mobile EDC Access

  As clinical studies become increasingly decentralized, learn why study teams need to be able to monitor the influx of data in real time to ensure the integrity and success of modern trials.

• Making The Lives Of Patients And Research Sites Easier

  Most clinical trials overlook one crucial factor: giving sites and patients a voice in how studies are run. That’s starting to change—and the impact is significant.

• Empowering Freenome: Large-Scale Data Quality And Compliance

  Delve into five ways this biotech company was able to successfully deliver data quality and compliance for large-scale trials while developing next-generation blood tests for early cancer detection.

• Bridging the Gap: Ensuring Sites are Successful

  Get an overview of how one site success department is helping clinical research sites receive training, support, and access to innovative technology to improve operations.

• Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial

  Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.

• Hidden Costs Of Data Cleaning: Build Quality At The Source

  Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.